Last Updated:
10 Mar 2026, 03:29:32 PM (IST)
Vaishali Pharma Limited
NSE: VAISHALI
NSE
6.51
0.00 (0.00%)
Prev Close
6.51
Open Price
6.78
Volume
114,982
Today Low / High
6.5 / 6.78
52 WK Low / High
6.4 / 15.24
Range
6 - 7
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 6.51, with a change of 0 (0%). The expected target range on the NSE is between 6 - 7. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.
Vaishali Pharma Limited Graph
Vaishali Pharma Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Vaishali Pharma Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 6.51, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 6.51 | 6.58 | 5.92 - 7.23 |
| 6.64 | 5.31 - 7.97 | ||
| 6.71 | 4.69 - 8.72 | ||
| Bearish Scenario | 6.51 | 6.44 | 5.80 - 7.09 |
| 6.38 | 5.10 - 7.66 | ||
| 6.31 | 4.42 - 8.21 |
Overview of Vaishali Pharma Limited
ISIN
INE972X01022
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
238,565
Market Cap
727,833,680
Last Dividend
0
Official Website
IPO Date
2017-08-22
DCF Diff
20.36
DCF
-9
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 99.03 Cr | 88.74 Cr | 10.29 Cr | 0.1039 | 0.00 Cr | 8.12 Cr | -0.40 Cr | 0.82 Cr | 0.56 | 3.30 Cr | 0.0083 |
| 2024-03-31 | 86.28 Cr | 74.42 Cr | 9.64 Cr | 0.1118 | 0.00 Cr | 0.55 Cr | 0.67 Cr | 0.72 Cr | 0.57 | 3.17 Cr | 0.0083 |
| 2023-03-31 | 69.66 Cr | 54.68 Cr | 12.92 Cr | 0.1854 | 0.00 Cr | 0.38 Cr | 12.35 Cr | 6.60 Cr | 6.26 | 11.36 Cr | 0.0948 |
| 2022-03-31 | 75.82 Cr | 63.50 Cr | 8.04 Cr | 0.1060 | 0.00 Cr | 0.42 Cr | 6.22 Cr | 4.02 Cr | 3.82 | 8.64 Cr | 0.0531 |
| 2021-03-31 | 53.77 Cr | 46.15 Cr | 6.16 Cr | 0.1145 | 0.00 Cr | 0.26 Cr | 1.77 Cr | 1.05 Cr | 0.99 | 4.44 Cr | 0.0195 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1.84 Cr | 109.84 Cr | 44.93 Cr | 64.9161 Cr | 12.55 Cr | 10.71 Cr | 4.81 Cr | 1.16 Cr | 0.00 Cr | 0.00 Cr | 2.37 Cr | 40.0529 Cr |
| 2024-03-31 | 1.46 Cr | 79.96 Cr | 37.12 Cr | 42.8394 Cr | 13.49 Cr | 12.03 Cr | 0.38 Cr | 1.46 Cr | 2.72 Cr | 0.00 Cr | 0.43 Cr | 33.0820 Cr |
| 2023-03-31 | 0.53 Cr | 78.91 Cr | 38.38 Cr | 40.5312 Cr | 14.74 Cr | 14.21 Cr | 3.05 Cr | 1.80 Cr | 1.76 Cr | 0.00 Cr | 1.64 Cr | 32.0780 Cr |
| 2022-03-31 | 1.16 Cr | 81.62 Cr | 55.27 Cr | 26.3542 Cr | 20.81 Cr | 19.65 Cr | 0.63 Cr | 0.90 Cr | 2.50 Cr | 0.00 Cr | 1.08 Cr | 51.9369 Cr |
| 2021-03-31 | 0.31 Cr | 86.12 Cr | 63.70 Cr | 22.4186 Cr | 17.85 Cr | 17.54 Cr | 0.59 Cr | 0.97 Cr | 2.11 Cr | 0.00 Cr | 1.08 Cr | 59.2605 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -18.0383 Cr | -0.1881 Cr | 18.4911 Cr | -19.7360 Cr | 0.2647 Cr | 1.8429 Cr | -0.3046 Cr | 0.8173 Cr | -0.9502 Cr | 0.0000 Cr | -4.4304 Cr |
| 2024-03-31 | 0.8067 Cr | 1.2027 Cr | -1.4158 Cr | 0.2711 Cr | 0.5936 Cr | 1.5783 Cr | -0.1110 Cr | 0.7189 Cr | -1.0539 Cr | 0.0000 Cr | 2.6704 Cr |
| 2023-03-31 | 1.0797 Cr | 0.2821 Cr | -1.7324 Cr | 0.7825 Cr | -0.3706 Cr | 0.9847 Cr | -0.2972 Cr | 8.8453 Cr | -4.5040 Cr | 0.0000 Cr | -2.4211 Cr |
| 2022-03-31 | 1.3186 Cr | -0.8468 Cr | 0.4175 Cr | 0.4538 Cr | 0.8893 Cr | 1.3553 Cr | -0.8648 Cr | 5.7284 Cr | 3.1880 Cr | 0.0000 Cr | -0.0407 Cr |
| 2021-03-31 | 2.0111 Cr | -0.1103 Cr | -1.8116 Cr | 1.8851 Cr | 0.0892 Cr | 0.4660 Cr | -0.1260 Cr | 1.4045 Cr | 0.9376 Cr | 0.0000 Cr | 0.2919 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 24.65 Cr | 21.79 Cr | 2.87 Cr | 0.1163 | 1.43 Cr | 1.32 Cr | 0.10 | 1.56 Cr | 0.0535 |
| 2025-09-30 | 33.45 Cr | 30.50 Cr | 2.95 Cr | 0.0881 | 1.22 Cr | 1.19 Cr | 0.09 | 2.23 Cr | 0.0355 |
| 2025-06-30 | 23.75 Cr | 20.03 Cr | 3.72 Cr | 0.1564 | 2.93 Cr | 1.28 Cr | 0.10 | 1.35 Cr | 0.0539 |
| 2025-03-31 | 32.25 Cr | 31.51 Cr | 0.74 Cr | 0.0229 | -6.16 Cr | -4.29 Cr | -2.92 | -5.04 Cr | -0.1331 |
| 2024-12-31 | 27.91 Cr | 23.74 Cr | 4.18 Cr | 0.1497 | 1.24 Cr | 1.44 Cr | 0.98 | 2.43 Cr | 0.0517 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 1.05 Cr | 0.00 Cr | 1.05 Cr | 51.22 Cr | 1.90 Cr | 111.40 Cr | 1.41 Cr | 121.92 Cr | 54.54 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 1.84 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -64.92 Cr |
| 2025-03-31 | 1.84 Cr | 0.00 Cr | 1.84 Cr | 46.72 Cr | 4.81 Cr | 104.48 Cr | 1.16 Cr | 109.84 Cr | 44.93 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -67.76 Cr |
| 2024-09-30 | 1.02 Cr | 28.31 Cr | 29.33 Cr | 43.28 Cr | 1.90 Cr | 98.39 Cr | 1.31 Cr | 103.95 Cr | 36.19 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1.28 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | -4.29 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 1.44 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 1.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 1.70 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2024-10-15 | October 15, 24 | 5:1 |
| 2019-10-25 | October 25, 19 | 8:5 |
| 2019-10-17 | October 17, 19 | 8:5 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,812.80 | ₹4,349,514,433,616.00 | ₹3,298,187.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,372.00 | ₹1,691,565,791,760.00 | ₹298,134.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,427.80 | ₹1,498,568,719,232.00 | ₹373,853.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,314.60 | ₹1,094,510,791,983.00 | ₹2,328,593.00 |
| Lupin Limited | LUPIN | ₹2,337.40 | ₹1,068,292,308,200.00 | ₹1,118,737.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹923.10 | ₹928,854,596,169.00 | ₹548,985.00 |
| Mankind Pharma Limited | MANKIND | ₹2,237.70 | ₹923,733,909,614.00 | ₹1,043,890.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,285.90 | ₹746,852,807,016.00 | ₹2,197,557.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,616.50 | ₹671,536,822,500.00 | ₹127,559.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,225.80 | ₹628,122,560,672.00 | ₹1,554,299.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,038.00 | ₹560,371,132,116.00 | ₹1,367,251.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,491.20 | ₹378,323,729,882.00 | ₹56,999.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,999.90 | ₹374,794,378,438.00 | ₹123,025.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹2,117.40 | ₹339,967,004,084.00 | ₹706,890.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,567.80 | ₹297,211,828,212.00 | ₹871,597.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,815.50 | ₹220,387,500,000.00 | ₹3,477.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,327.40 | ₹215,692,105,131.00 | ₹576,727.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹1,039.20 | ₹186,130,976,904.00 | ₹2,029,982.00 |
| Eris Lifesciences Limited | ERIS | ₹1,351.10 | ₹184,042,641,430.00 | ₹100,690.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹12,597.00 | ₹161,618,111,733.00 | ₹24,766.00 |
| Granules India Limited | GRANULES | ₹581.30 | ₹141,063,489,700.00 | ₹712,670.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹712.35 | ₹140,021,741,381.00 | ₹50,451.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹812.35 | ₹128,651,664,788.00 | ₹293,109.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,684.10 | ₹128,011,297,234.00 | ₹43,345.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹940.65 | ₹115,451,618,400.00 | ₹42,515.00 |
| Cohance Lifesciences Limited | COHANCE | ₹295.60 | ₹113,086,846,584.00 | ₹907,550.00 |
| Viyash Scientific Limited | VIYASH | ₹197.45 | ₹86,151,137,188.00 | ₹1,162,070.00 |
| Procter & Gamble Health Limited | PGHL | ₹4,892.10 | ₹81,205,836,682.00 | ₹11,986.00 |
| Strides Pharma Science Limited | STAR | ₹872.90 | ₹80,457,562,051.00 | ₹160,822.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹500.60 | ₹76,642,890,235.00 | ₹265,090.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹338.65 | ₹66,233,781,988.00 | ₹758,443.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹686.70 | ₹62,254,676,925.00 | ₹118,363.00 |
| FDC Limited | FDC | ₹378.05 | ₹61,550,352,256.00 | ₹52,686.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹124.37 | ₹40,360,749,900.00 | ₹1,617,219.00 |
| Innova Captab Limited | INNOVACAP | ₹703.35 | ₹40,249,153,812.00 | ₹21,279.00 |
| Suven Life Sciences Limited | SUVEN | ₹144.43 | ₹33,500,801,218.00 | ₹421,279.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹301.45 | ₹32,847,579,134.00 | ₹64,137.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹353.45 | ₹32,259,381,500.00 | ₹243,536.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹1,908.60 | ₹31,566,364,029.00 | ₹7,443.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹289.65 | ₹29,046,827,863.00 | ₹71,884.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹509.55 | ₹25,843,919,953.00 | ₹191,509.00 |
Key Executives
Chairman & MD
Atul Arvind Vasani
Gender: male
Year Born: 1964
Chief Financial Officer & Executive Director
Dewansh Ajay Vasani
Gender: male
Year Born: 1995
Chief Executive Officer
Hemanth Damodar Pathak
Gender: male
Year Born: 1961
Whole Time Director
Jagruti Atul Vasani
Gender: female
Year Born: 1966
Chief Operating Officer
Priyanka Vasani
Gender: female
Year Born: 1992
Company Secretary & Compliance Officer
Vishwa Bipinbhai Mekhia
Gender: female
Year Born: 1991
FAQs about Vaishali Pharma Limited
Who is the CEO of the company?
The CEO is Hemanth Damodar Pathak.
What is the current market price of the stock?
The current price is ₹6.79.
What is the 52-week price range?
The range is ₹6.5-15.24.
What is the market capitalization of the company?
The market capitalization is ₹72.78 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -174.07.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Vaishali Pharma Limited (ISIN: INE972X01022) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹72.78 crores and an average daily volume of 238,565 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.